Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Johannes Blom"'
Autor:
Hans-Olov Adami, Lise M Helsingen, Michael Bretthauer, Mette Kalager, Jingru Yu, Weimin Ye, Paulina Wieszczy, Magnus Løberg, Johannes Blom, Erle Refsum, Vera Perrin, Amanda Högdén
Publikováno v:
BMJ Open Gastroenterology, Vol 10, Iss 1 (2023)
Objective To estimate the risk of non-Hodgkin’s lymphoma (NHL) and Hodgkin’s lymphoma (HL) in patients with inflammatory bowel disease (IBD).Design We undertook a two-country population cohort study with all patients diagnosed with IBD in Norway
Externí odkaz:
https://doaj.org/article/eea55344b0ab45ea9e4dc2309f3850ea
Autor:
Jingru Yu, Erle Refsum, Lise M. Helsingen, Trine Folseraas, Alexander Ploner, Paulina Wieszczy, Ishita Barua, Henriette C. Jodal, Espen Melum, Magnus Løberg, Johannes Blom, Michael Bretthauer, Hans‐Olov Adami, Mette Kalager, Weimin Ye
Publikováno v:
United European Gastroenterology Journal. 10:212-224
Background There is continued uncertainty regarding the risks of hepato-pancreato-biliary cancers in patients with inflammatory bowel disease (IBD) with or without concomitant primary sclerosing cholangitis (PSC). Objective To give updated estimates
Autor:
Rasmus Gantzel, Paulina Wieszczy, Erle Refsum, Tine Jess, Lone Larsen, Michael Bretthauer, Per O Vandvik, Johannes Blom, Rune Erichsen, Mette Kalager, Lise Helsingen
Publikováno v:
Gantzel, R, Wieszczy, P, Refsum, E, Jess, T, Larsen, L, Bretthauer, M, Vandvik, P O, Blom, J, Erichsen, R, Kalager, M & Helsingen, L 2023, ' Prognostic models for colorectal cancer incidence and mortality in patients with inflammatory bowel disease ', Cochrane Database of Systematic Reviews, vol. 2023, no. 1, CD015434 . https://doi.org/10.1002/14651858.CD015434
Gantzel, R H B, Wieszczy, P, Refsum, E, Jess, T, Larsen, L, Bretthauer, M, Vandvik, P O, Blom, J, Erichsen, R, Kalager, M & Helsingen, L 2023, ' Prognostic models for colorectal cancer incidence and mortality in patients with inflammatory bowel disease ', Cochrane Database of Systematic Reviews . https://doi.org/10.1002/14651858.CD015434
Gantzel, R H B, Wieszczy, P, Refsum, E, Jess, T, Larsen, L, Bretthauer, M, Vandvik, P O, Blom, J, Erichsen, R, Kalager, M & Helsingen, L 2023, ' Prognostic models for colorectal cancer incidence and mortality in patients with inflammatory bowel disease ', Cochrane Database of Systematic Reviews . https://doi.org/10.1002/14651858.CD015434
Objectives: This is a protocol for a Cochrane Review (prognosis). The objectives are as follows:. Primary objectives The primary objectives are to identify, describe, and appraise all prognostic models developed to predict colorectal cancer incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39d0299a2e5735dc16c6264b03e04c0
https://vbn.aau.dk/da/publications/6137f19a-e7ef-491e-8e62-17e8afdf4471
https://vbn.aau.dk/da/publications/6137f19a-e7ef-491e-8e62-17e8afdf4471
Autor:
Jingru Yu, Erle Refsum, Paulina Wieszczy, Lise M Helsingen, Vera Perrin, Amanda Högdén, Magnus Løberg, Johannes Blom, Michael Bretthauer, Hans-Olov Adami, Weimin Ye, Mette Kalager
Publikováno v:
BMJ Open Gastroenterology. 10:e001037
ObjectiveTo estimate the risk of non-Hodgkin’s lymphoma (NHL) and Hodgkin’s lymphoma (HL) in patients with inflammatory bowel disease (IBD).DesignWe undertook a two-country population cohort study with all patients diagnosed with IBD in Norway an
Publikováno v:
Statistical methods in medical research. 31(8)
A cancer diagnosis is part of a complex stochastic process, which involves patient's characteristics, diagnosing methods, an initial assessment of cancer progression, treatments and a certain outcome of interest. To evaluate the performance of diagno
Autor:
Anna Forsberg, Marcus Westerberg, Chris Metcalfe, Robert Steele, Johannes Blom, Lars Engstrand, Kaisa Fritzell, Mikael Hellström, Lars-Åke Levin, Christian Löwbeer, Andreas Pischel, Ulf Strömberg, Sven Törnberg, Yvonne Wengström, Anders Ekbom, Lars Holmberg, Rolf Hultcrantz
Publikováno v:
Fosberg, A, Westerberg, M, Metcalfe, C, Steele, R, Blom, J, Engstrand, L, Fritzell, K, Hellstrom, M, Levin, L-A, Lowbeer, C, Pischel, A, Stromberg, U, Tornberg, S, Wengstrom, Y, Ekborn, A, Holmberg, L & Hultcrantz, R 2022, ' Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO) : preliminary report of a randomised controlled trial ', Lancet Gastroenterology and Hepatology, vol. 7, no. 6, pp. 513-521 . https://doi.org/10.1016/S2468-1253(21)00473-8
Background: Screening for colorectal cancer is done with lower gastrointestinal endoscopy or stool-based tests. There is little evidence from randomised trials to show primary colonoscopy reduces mortality in colorectal cancer. We aimed to investigat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9f75cab6fcc29a16e79c449219712c
https://hdl.handle.net/1983/1ac4c6f6-3c5a-4b83-a2b2-376c89baee20
https://hdl.handle.net/1983/1ac4c6f6-3c5a-4b83-a2b2-376c89baee20
Publikováno v:
Journal of medical screening. 29(3)
Objective To evaluate interval cancers (IC) in the population-based Swedish regional colorectal cancer (CRC) screening program of Stockholm-Gotland, which uses gender-specific cut-off levels for the fecal immunochemical test (FIT). Methods All indivi
Publikováno v:
Journal of medical screening. 28(4)
Objective In the population-based Swedish regional colorectal cancer (CRC) screening program of Stockholm–Gotland using the fecal immunochemical test (FIT), gender-specific cut-off levels of fecal hemoglobin are applied, since previous studies have
Autor:
Lennart Johannes Blom
Despite the progress in diagnostic testing and management of life-threatening arrhythmia's over the last few decades in a small part of the survivors a cause for the arrhythmia remains unknown. This group is known as idiopathic ventricular fibrillati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ddbc6808ebb810e1bbd6b14328c5c7f
https://dspace.library.uu.nl/handle/1874/399813
https://dspace.library.uu.nl/handle/1874/399813
Autor:
Marika Sventelius, Deborah Saraste, Sven Törnberg, K. Miriam Elfström, Christian Löwbeer, Daniel Öhman, Johannes Blom
Publikováno v:
Journal of Medical Screening. 26:92-97
Objective Using quantitative Faecal Immunochemical Test (FIT) in colorectal cancer screening enables adjustment of the cut-off for a positive test. As men have higher stool blood levels and higher prevalence of colorectal neoplasia, different cut-off